Sports Drug Testing Market on Track to Hit US$ 20.6 Billion by 2032-FMI Study

Globally, the sports drug testing industry is expected to be valued US$ 20.6 billion in 2032 and US$ 13.4 billion in 2022. Over the next ten years, it is anticipated that the strict regulations requiring government agencies to conduct drug and alcohol tests will be implemented globally will spur growth. Drug use is prevalent at all levels …

Intravascular Imaging Market Set to Reach US$ 656.29 Million by 2033-FMI Study

It is projected that the intravascular imaging industry will be valued US$ 387.8 million by 2023. By 2033, the market is projected to be valued US$ 656.29 million. It is projected that the market will expand at a compound annual growth rate (CAGR) of 5.4% from 2023 to 2033. Over the projected period, further technological innovation, especially …

Pipette Controller Market Poised to Surpass US$ 263.6 Million by 2033-FMI Study

The global pipette controller industry, currently valued at around US$ 193 million in 2023, is on a steady upward trajectory. Industry experts anticipate that by the year 2033, the market is set to exceed US$ 263.6 million, reflecting a projected Compound Annual Growth Rate (CAGR) of 3.2%. Pipette controllers, essential tools in laboratories and research settings, …

Cell Line Development Market Soars with a 7.7% CAGR, Setting Sights on a US$ 10.6 Billion Valuation by 2033-FMI Study

With a 7.7% compound annual growth rate (CAGR) from 2023 to 2033, the global cell line development industry is projected to reach US$ 5.06 billion in 2023 and reach US$ 10.6 billion by 2033. The market was estimated to be worth US$ 4.7 billion in 2022. The substantial growth of the cell line development market is predominantly …

Cell Culture Incubators Market Envisions a Remarkable US$ 4,305.1 Million Valuation by 2032-FMI Study

As per the projections by Future Market Insight, the global cell culture incubator market is set to experience remarkable expansion, reaching an impressive value of US$ 4,305.1 million by 2033. This growth is likely to be driven by a steady CAGR of 6.4%, showcasing a substantial increase from its estimated worth of US$ 2,315.5 million in 2023. …

Dental Implantology Software Market Poised to Reach US$ 278.2 Million by 2032-FMI Study

Future Market Insights (FMI) predicts that the demand for a simpler and faster implant procedure will lead to a growth in the worldwide dental implantology software market. With the help of this programme, the patient spends less time in surgery and the dental team can analyse all procedures before surgery, which lowers the cost of the …

Global Autoimmune Disease Therapeutics Market, with projected figures of US$ 123,507.30 Million by 2033 according to FMI

The autoimmune disease therapeutics market will likely reach US$ 71,466.47 million in 2023, growing at a moderate rate of 5.6% over the course of the forecast period. By 2033, the market is projected to increase in size and reach US$ 123,507.30 million. According to Future Market Insights’ data, the historical CAGR was 3.6%. The autoimmune …

Global Sennosides Market, expected to reach US$ 548.5 Million by 2033, is heavily influenced by the rising demand for natural laxatives, according to FMI

In 2023, the global sennosides market is anticipated to be valued at US$ 359.5 million. Between 2023 and 2033, demand for sennosides is expected to expand at a 4.3% CAGR, totaling a market value of US$ 548.5 million. The sennosides industry is driven by several factors contributing to its market growth and demand. One key …

Global Portable Bioprocessing Bioreactors Market is projected to hit US$ 6.75 Billion by 2033, powered by a 14.6% CAGR | FMI

The portable bioprocessing bioreactors market is anticipated to thrive at a strong CAGR of 14.6% between 2023 and 2033. The market is expected to have a market share of US$ 6.75 billion by 2033, while it is likely to be valued at US$ 1.73 billion in 2023. The growing scope of tissue engineering and fundamental …

Global Therapeutic Apheresis Industry is on track to achieve a valuation of US$ 5,264.4 Million by 2033 | FMI

According to forecasts, the therapeutic apheresis industry is expected to be US$ 2,717.9 million in 2023 and US$ 5,264.4 million by 2033, the demand for therapeutic apheresis is estimated to rise at a CAGR of 6.8% during the forecast period. The rising prevalence of diseases, increased demand for blood components, and the safety that goes along with …